Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 360 mg - capsule, modified release - excipient ingredients: purified talc; sodium lauryl sulfate; methacrylic acid copolymer; povidone; simethicone; diethyl phthalate; tributyl acetylcitrate; maize starch; sucrose; titanium dioxide; brilliant blue fcf; potable water; gelatin; silicon dioxide - diltiazem sandoz cd is indicated for the treatment of hypertension. diltiazem sandoz cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 240 mg - capsule, modified release - excipient ingredients: ethylcellulose; simethicone; purified talc; castor oil; tributyl acetylcitrate; white beeswax; methacrylic acid copolymer; titanium dioxide; gelatin; colloidal anhydrous silica; brilliant blue fcf; stearic acid; fumaric acid; maize starch; sucrose - diltiazem sandoz cd is indicated for the treatment of hypertension. diltiazem sandoz cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 180 mg - capsule, modified release - excipient ingredients: fumaric acid; gelatin; methacrylic acid copolymer; brilliant blue fcf; white beeswax; stearic acid; colloidal anhydrous silica; simethicone; ethylcellulose; titanium dioxide; tributyl acetylcitrate; castor oil; purified talc; maize starch; sucrose - diltiazem sandoz cd is indicated for the treatment of hypertension. diltiazem sandoz cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Canada - English - Health Canada

jamp pharma corporation - diltiazem hydrochloride - capsule (controlled-delivery) - 120mg - diltiazem hydrochloride 120mg

Canada - English - Health Canada

jamp pharma corporation - diltiazem hydrochloride - capsule (controlled-delivery) - 180mg - diltiazem hydrochloride 180mg

Canada - English - Health Canada

jamp pharma corporation - diltiazem hydrochloride - capsule (controlled-delivery) - 240mg - diltiazem hydrochloride 240mg

Canada - English - Health Canada

jamp pharma corporation - diltiazem hydrochloride - capsule (controlled-delivery) - 300mg - diltiazem hydrochloride 300mg

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - diltiazem hydrochloride -

Canada - English - Health Canada

ratiopharm inc division of teva canada limited - diltiazem hydrochloride - capsule (controlled-delivery) - 120mg - diltiazem hydrochloride 120mg - miscellaneous calcium-channel blocking agents

Canada - English - Health Canada

ratiopharm inc division of teva canada limited - diltiazem hydrochloride - capsule (controlled-delivery) - 180mg - diltiazem hydrochloride 180mg - miscellaneous calcium-channel blocking agents